These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16952200)
1. Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Khor TO; Hu R; Shen G; Jeong WS; Hebbar V; Chen C; Xu C; Nair S; Reddy B; Chada K; Kong AN Biopharm Drug Dispos; 2006 Dec; 27(9):407-20. PubMed ID: 16952200 [TBL] [Abstract][Full Text] [Related]
2. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Hu R; Khor TO; Shen G; Jeong WS; Hebbar V; Chen C; Xu C; Reddy B; Chada K; Kong AN Carcinogenesis; 2006 Oct; 27(10):2038-46. PubMed ID: 16675473 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Shen G; Khor TO; Hu R; Yu S; Nair S; Ho CT; Reddy BS; Huang MT; Newmark HL; Kong AN Cancer Res; 2007 Oct; 67(20):9937-44. PubMed ID: 17942926 [TBL] [Abstract][Full Text] [Related]
4. [Sulforaphane--a possible agent in prevention and therapy of cancer]. Tomczyk J; Olejnik A Postepy Hig Med Dosw (Online); 2010 Nov; 64():590-603. PubMed ID: 21160094 [TBL] [Abstract][Full Text] [Related]
5. Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane. Sharma R; Sharma A; Chaudhary P; Sahu M; Jaiswal S; Awasthi S; Awasthi YC Free Radic Biol Med; 2012 Jun 1-15; 52(11-12):2177-85. PubMed ID: 22579574 [TBL] [Abstract][Full Text] [Related]
6. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Myzak MC; Dashwood RH Cancer Lett; 2006 Feb; 233(2):208-18. PubMed ID: 16520150 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Hu R; Xu C; Shen G; Jain MR; Khor TO; Gopalkrishnan A; Lin W; Reddy B; Chan JY; Kong AN Cancer Lett; 2006 Nov; 243(2):170-92. PubMed ID: 16516379 [TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Cheung KL; Khor TO; Kong AN Pharm Res; 2009 Jan; 26(1):224-31. PubMed ID: 18841446 [TBL] [Abstract][Full Text] [Related]
10. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Gerhäuser C; You M; Liu J; Moriarty RM; Hawthorne M; Mehta RG; Moon RC; Pezzuto JM Cancer Res; 1997 Jan; 57(2):272-8. PubMed ID: 9000567 [TBL] [Abstract][Full Text] [Related]
11. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. Myzak MC; Dashwood WM; Orner GA; Ho E; Dashwood RH FASEB J; 2006 Mar; 20(3):506-8. PubMed ID: 16407454 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. Heiss E; Herhaus C; Klimo K; Bartsch H; Gerhäuser C J Biol Chem; 2001 Aug; 276(34):32008-15. PubMed ID: 11410599 [TBL] [Abstract][Full Text] [Related]
13. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Shen G; Xu C; Chen C; Hebbar V; Kong AN Cancer Chemother Pharmacol; 2006 Feb; 57(3):317-27. PubMed ID: 16170570 [TBL] [Abstract][Full Text] [Related]
14. Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells. Fimognari C; Lenzi M; Sciuscio D; Cantelli-Forti G; Hrelia P In Vivo; 2007; 21(2):377-80. PubMed ID: 17436591 [TBL] [Abstract][Full Text] [Related]
15. Dual roles of sulforaphane in cancer treatment. Xu T; Ren D; Sun X; Yang G Anticancer Agents Med Chem; 2012 Nov; 12(9):1132-42. PubMed ID: 22583415 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related]
17. Chemopreventive activity of sulforaphane. Jiang X; Liu Y; Ma L; Ji R; Qu Y; Xin Y; Lv G Drug Des Devel Ther; 2018; 12():2905-2913. PubMed ID: 30254420 [TBL] [Abstract][Full Text] [Related]
18. Chemopreventive agent sulforaphane enhances radiosensitivity in human tumor cells. Yu D; Sekine-Suzuki E; Xue L; Fujimori A; Kubota N; Okayasu R Int J Cancer; 2009 Sep; 125(5):1205-11. PubMed ID: 19452523 [TBL] [Abstract][Full Text] [Related]
19. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Hunakova L; Sedlakova O; Cholujova D; Gronesova P; Duraj J; Sedlak J Neoplasma; 2009; 56(6):548-56. PubMed ID: 19728765 [TBL] [Abstract][Full Text] [Related]
20. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]